After BWX Technologies had its best day on record, Cathie Wood’s ARK Invest shed shares of the nuclear play across two of its flagship funds. The sale included 2,639 shares by the which is concentrated in so-called disruptive technology and dominated by names such as Crispr Therapeutics and Advanced Micro Devices As of Friday, ARK Innovation held 303,133 BWX shares valued at roughly $69.8 million, or 1.17% of the portfolio by weight. The second fund to sell was the ARK Autonomous Technology & Robotics ETF which shed 839 shares.